BIESF
Price
$30.48
Change
-$0.00 (-0.00%)
Updated
Mar 13 closing price
BSFAF
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Jun 13 closing price
Ad is loading...

BIESF vs BSFAF

Header iconBIESF vs BSFAF Comparison
Open Charts BIESF vs BSFAFBanner chart's image
Biotest AG
Price$30.48
Change-$0.00 (-0.00%)
Volume$200
CapitalizationN/A
BSF Enterprise
Price$0.05
Change-$0.00 (-0.00%)
Volume$1K
CapitalizationN/A
View a ticker or compare two or three
BIESF vs BSFAF Comparison Chart
Loading...
VS
BIESF vs. BSFAF commentary
Oct 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIESF is a Sell and BSFAF is a Sell.

COMPARISON
Comparison
Oct 18, 2024
Stock price -- (BIESF: $30.48 vs. BSFAF: $0.05)
Brand notoriety: BIESF and BSFAF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BIESF: 100% vs. BSFAF: 100%
Market capitalization -- BIESF: $1.51B vs. BSFAF: $5.18M
BIESF [@Biotechnology] is valued at $1.51B. BSFAF’s [@Biotechnology] market capitalization is $5.18M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIESF’s FA Score shows that 2 FA rating(s) are green whileBSFAF’s FA Score has 0 green FA rating(s).

  • BIESF’s FA Score: 2 green, 3 red.
  • BSFAF’s FA Score: 0 green, 5 red.
According to our system of comparison, BIESF is a better buy in the long-term than BSFAF.

Price Growth

BIESF (@Biotechnology) experienced а 0.00% price change this week, while BSFAF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
BIESF($1.51B) has a higher market cap than BSFAF($5.18M). BIESF YTD gains are higher at: -11.908 vs. BSFAF (-70.149). BIESF has higher annual earnings (EBITDA): 201M vs. BSFAF (-1.68M). BIESF has more cash in the bank: 84.7M vs. BSFAF (1.37M). BIESF has higher revenues than BSFAF: BIESF (781M) vs BSFAF (67.2K).
BIESFBSFAFBIESF / BSFAF
Capitalization1.51B5.18M29,087%
EBITDA201M-1.68M-11,994%
Gain YTD-11.908-70.14917%
P/E Ratio6.33N/A-
Revenue781M67.2K1,162,202%
Total Cash84.7M1.37M6,164%
Total DebtN/A118K-
FUNDAMENTALS RATINGS
BIESF: Fundamental Ratings
BIESF
OUTLOOK RATING
1..100
46
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
PROFIT vs RISK RATING
1..100
67
SMR RATING
1..100
26
PRICE GROWTH RATING
1..100
71
P/E GROWTH RATING
1..100
87
SEASONALITY SCORE
1..100
49

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL232.150.37
+0.16%
Apple
SPY582.350.05
+0.01%
SPDR® S&P 500® ETF Trust
TSLA220.89-0.44
-0.20%
Tesla
BTC.X67399.836000-212.882810
-0.31%
Bitcoin cryptocurrency
GME21.41-0.25
-1.15%
GameStop Corp

BIESF and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIESF has been closely correlated with BSFAF. These tickers have moved in lockstep 86% of the time. This A.I.-generated data suggests there is a high statistical probability that if BIESF jumps, then BSFAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIESF
1D Price
Change %
BIESF100%
N/A
BSFAF - BIESF
86%
Closely correlated
N/A
SOLTF - BIESF
38%
Loosely correlated
-20.93%
YECO - BIESF
26%
Poorly correlated
N/A
NMRA - BIESF
24%
Poorly correlated
+1.68%
BIXT - BIESF
5%
Poorly correlated
+2.23%
More

BSFAF and

Correlation & Price change

A.I.dvisor indicates that over the last year, BSFAF has been closely correlated with BIESF. These tickers have moved in lockstep 86% of the time. This A.I.-generated data suggests there is a high statistical probability that if BSFAF jumps, then BIESF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSFAF
1D Price
Change %
BSFAF100%
N/A
BIESF - BSFAF
86%
Closely correlated
N/A
SOLTF - BSFAF
33%
Poorly correlated
-20.93%
YECO - BSFAF
25%
Poorly correlated
N/A
CERO - BSFAF
21%
Poorly correlated
-5.09%
MBCOF - BSFAF
8%
Poorly correlated
N/A
More